Bin Lai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Bin Lai has a total of 94 co-authors. Here are the top co-authors by number of shared publications:
- Ping Zheng
State Key Laboratory of Brain Function and Disorders, Institutes of Brain Science, MOE Frontier Center for Brain Science, Department of Neurology of Zhongshan Hospital, Fudan University, Shanghai, China
14 shared publications Dongyang Cui
State Key Laboratory of Medical Neurobiology Institutes of Brain Science MOE Frontier Center for Brain Science Department of Neurology of Zhongshan Hospital Fudan University Shanghai 200032 China
11 shared publicationsDa Shao
State Key Laboratory of Brain Function and Disorders, Institutes of Brain Science, MOE Frontier Center for Brain Science, Department of Neurology of Zhongshan Hospital, Fudan University, Shanghai, China
10 shared publicationsHuan Sheng
State Key Laboratory of Brain Function and Disorders, Institutes of Brain Science, MOE Frontier Center for Brain Science, Department of Neurology of Zhongshan Hospital, Fudan University, Shanghai, China
10 shared publicationsXinli Guo
State Key Laboratory of Brain Function and Disorders, Institutes of Brain Science, MOE Frontier Center for Brain Science, Department of Neurology of Zhongshan Hospital, Fudan University, Shanghai, China
10 shared publications- Ming Chen
State Key Laboratory of Brain Function and Disorders, Institutes of Brain Science, MOE Frontier Center for Brain Science, Department of Neurology of Zhongshan Hospital, Fudan University, Shanghai, China
9 shared publications
Latest Publications
- 20 October 2026
- Published by Springer Nature in Molecular Psychiatry
- p. 1-16
Two distinct projection pathways converge onto the same BLA neurons to contribute to fear memory retrieval
Studying the neural circuits that mediate context-induced fear memory retrieval is of importance to develop new therapeutic approaches to prevent post-traumatic stress disorder relapse. The basolateral amygdala (BLA) is crucial for context-induced retrieval of fear memory. Previous studies indicate that projection neurons from the ventral hippocampus CA1 (vCA1) to the BLA (vCA1-BLA neurons) mediate context-induced retrieval of fear memory. However, it remains unclear whether other projection neurons to the BLA are involved in context-induced retrieval of fear memory and how they interact with vCA1-BLA neurons. Our findings indicate that the postrhinal cortex (POR) to the BLA (POR-BLA) neurons are also involved in context-induced retrieval of fear memory. These neurons innervate the same BLA neurons as vCA1-BLA neurons and participate in fear memory retrieval. These results suggest that two different projection neurons of POR-BLA and vCA1-BLA innervate on the same BLA neurons and POR-BLA neurons and vCA1-BLA neuron contribute to fear memory retrieval. These findings provide new insights into the neural mechanisms underlying fear memory retrieval.
- 20 October 2026
- Published by Springer Nature in Molecular Psychiatry
- p. 1-16
Two distinct projection pathways converge onto the same BLA neurons to contribute to fear memory retrieval
Studying the neural circuits that mediate context-induced fear memory retrieval is of importance to develop new therapeutic approaches to prevent post-traumatic stress disorder relapse. The basolateral amygdala (BLA) is crucial for context-induced retrieval of fear memory. Previous studies indicate that projection neurons from the ventral hippocampus CA1 (vCA1) to the BLA (vCA1-BLA neurons) mediate context-induced retrieval of fear memory. However, it remains unclear whether other projection neurons to the BLA are involved in context-induced retrieval of fear memory and how they interact with vCA1-BLA neurons. Our findings indicate that the postrhinal cortex (POR) to the BLA (POR-BLA) neurons are also involved in context-induced retrieval of fear memory. These neurons innervate the same BLA neurons as vCA1-BLA neurons and participate in fear memory retrieval. These results suggest that two different projection neurons of POR-BLA and vCA1-BLA innervate on the same BLA neurons and POR-BLA neurons and vCA1-BLA neuron contribute to fear memory retrieval. These findings provide new insights into the neural mechanisms underlying fear memory retrieval.
- Open Access
- 23 August 2025
- Published by Wiley in Advanced Science
- Vol. 12 (42) , e03409
Corticosterone Contributes to Context‐Triggered Retrieval of Morphine Withdrawal Memories by Acting on Basolateral Amygdala Neurons Projecting to Nucleus Accumbens Core
Context‐triggered retrieval of drug withdrawal memories (CTR‐DWM) is a major cause of drug relapse. Most studies of the context‐triggered retrieval of morphine withdrawal memories (CTR‐MWM) have mainly focused on the functional interactions within the central structures of the brain. It remains unknown how an increase in corticosterone, which is an important response under drug withdrawal state, participates in CTR‐MWM. The present results show that corticosterone contributes to CTR‐MWM; within the basolateral amygdala (BLA), it is the mineralocorticoid receptor (MR), rather than the glucocorticoid receptor (GR), activated by corticosterone that mediates CTR‐MWM; MR of BLA neurons projecting to the nucleus accumbens core (BLA →NAcC ) mediates CTR‐MWM; MR increases presynaptic glutamate release and participates in dopamine D1 receptor ‐induced increase in presynaptic glutamate release and postsynaptic AMPA (α‐Amino‐3‐hydroxy‐5‐methyl‐4‐isoxazolepropionic Acid) currents; MR increases intrinsic excitability of BLA →NAcC neurons during CTR‐MWM. These results suggest that corticosterone contributes to CTR‐MWM by activating BLA →NAcC neurons through MR pathways, uncovering a link between a systemic hormonal response and a specific CTR‐MWM process.
- 23 August 2025
- Published by Wiley in Advanced Science
- Vol. 12 (42) , e03409
Open AccessCorticosterone Contributes to Context‐Triggered Retrieval of Morphine Withdrawal Memories by Acting on Basolateral Amygdala Neurons Projecting to Nucleus Accumbens Core
Context‐triggered retrieval of drug withdrawal memories (CTR‐DWM) is a major cause of drug relapse. Most studies of the context‐triggered retrieval of morphine withdrawal memories (CTR‐MWM) have mainly focused on the functional interactions within the central structures of the brain. It remains unknown how an increase in corticosterone, which is an important response under drug withdrawal state, participates in CTR‐MWM. The present results show that corticosterone contributes to CTR‐MWM; within the basolateral amygdala (BLA), it is the mineralocorticoid receptor (MR), rather than the glucocorticoid receptor (GR), activated by corticosterone that mediates CTR‐MWM; MR of BLA neurons projecting to the nucleus accumbens core (BLA →NAcC ) mediates CTR‐MWM; MR increases presynaptic glutamate release and participates in dopamine D1 receptor ‐induced increase in presynaptic glutamate release and postsynaptic AMPA (α‐Amino‐3‐hydroxy‐5‐methyl‐4‐isoxazolepropionic Acid) currents; MR increases intrinsic excitability of BLA →NAcC neurons during CTR‐MWM. These results suggest that corticosterone contributes to CTR‐MWM by activating BLA →NAcC neurons through MR pathways, uncovering a link between a systemic hormonal response and a specific CTR‐MWM process.
- Open Access
- 13 June 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (24) , eadt4771
Instant noninvasive near-infrared deep brain stimulation using optoelectronic nanoparticles without genetic modification
Noninvasive transcranial neuromodulation of deep brain regions is a longstanding goal in neuroscience. While optogenetics enables remote neural control, it is constrained by shallow tissue penetration of visible light and delayed onset due to required opsin expression. Here, we introduce a neuromodulation technique using hybrid upconversion and photovoltaic (HUP) nanoparticles, which eliminates the need for genetic modification and affords near-infrared (NIR) activation of neurons in wild-type mice. This method converts deeply penetrating NIR light into localized electrical stimuli, enabling immediate and precise modulation in deep brain. In vitro patch-clamp experiments confirm neuronal activation upon HUP application. In vivo, we achieve remote NIR neuromodulation in the medial septum and ventral tegmental area 7 days postinjection, effectively modulating neuronal activity, suppressing seizures, and triggering dopamine release. This minimally invasive approach offers a versatile tool kit for investigating neural processes in mammals, with potential applications across diverse brain regions through customizable nanoparticle engineering.
- 13 June 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (24) , eadt4771
Open AccessInstant noninvasive near-infrared deep brain stimulation using optoelectronic nanoparticles without genetic modification
Noninvasive transcranial neuromodulation of deep brain regions is a longstanding goal in neuroscience. While optogenetics enables remote neural control, it is constrained by shallow tissue penetration of visible light and delayed onset due to required opsin expression. Here, we introduce a neuromodulation technique using hybrid upconversion and photovoltaic (HUP) nanoparticles, which eliminates the need for genetic modification and affords near-infrared (NIR) activation of neurons in wild-type mice. This method converts deeply penetrating NIR light into localized electrical stimuli, enabling immediate and precise modulation in deep brain. In vitro patch-clamp experiments confirm neuronal activation upon HUP application. In vivo, we achieve remote NIR neuromodulation in the medial septum and ventral tegmental area 7 days postinjection, effectively modulating neuronal activity, suppressing seizures, and triggering dopamine release. This minimally invasive approach offers a versatile tool kit for investigating neural processes in mammals, with potential applications across diverse brain regions through customizable nanoparticle engineering.
- 17 May 2025
- Published by Springer Nature in Neuroscience Bulletin
- Vol. 41 (12) , 2272-2284
Genetic Variation A118G in the OPRM1 Gene Underlies the Dimorphic Response to Epidural Opioid-Induced Itch
Neuraxial opioids, widely used in obstetric and perioperative pain management, often lead to unwanted itch, reducing patient satisfaction. While the μ-opioid receptor has been implicated in opioid-induced itch, the genetic basis for variable itch incidence remains unknown. This study examined 3616 patients receiving epidural opioids, revealing an itch occurrence of 26.55%, with variations among opioid types and gender. Analysis of the OPRM1 gene identified six single-nucleotide polymorphisms, notably rs1799971 (A118G), that correlated with opioid-induced itch. Mouse models with an equivalent A112G mutation showed reduced neuraxial opioid-induced itch and light touch-evoked itch, mirroring human findings. The 118G allele demonstrated an anti-itch effect without impacting analgesia, addiction, or tolerance, offering insights for risk stratification and potential anti-itch pretreatment strategies.
- 17 May 2025
- Published by Springer Nature in Neuroscience Bulletin
- Vol. 41 (12) , 2272-2284
Genetic Variation A118G in the OPRM1 Gene Underlies the Dimorphic Response to Epidural Opioid-Induced Itch
Neuraxial opioids, widely used in obstetric and perioperative pain management, often lead to unwanted itch, reducing patient satisfaction. While the μ-opioid receptor has been implicated in opioid-induced itch, the genetic basis for variable itch incidence remains unknown. This study examined 3616 patients receiving epidural opioids, revealing an itch occurrence of 26.55%, with variations among opioid types and gender. Analysis of the OPRM1 gene identified six single-nucleotide polymorphisms, notably rs1799971 (A118G), that correlated with opioid-induced itch. Mouse models with an equivalent A112G mutation showed reduced neuraxial opioid-induced itch and light touch-evoked itch, mirroring human findings. The 118G allele demonstrated an anti-itch effect without impacting analgesia, addiction, or tolerance, offering insights for risk stratification and potential anti-itch pretreatment strategies.
- Open Access
- 6 February 2025
- Published by Elsevier in STAR Protocols
- Vol. 6 (1) , 103542
Protocol to study the role of medial entorhinal cortex-basolateral amygdala circuit in context-induced retrieval of morphine withdrawal memory in mice
- 6 February 2025
- Published by Elsevier in STAR Protocols
- Vol. 6 (1) , 103542
Open AccessProtocol to study the role of medial entorhinal cortex-basolateral amygdala circuit in context-induced retrieval of morphine withdrawal memory in mice
- Open Access
- 26 December 2023
- Published by Springer Nature in Molecular Psychiatry
- Vol. 29 (3) , 793-808
Different projection neurons of basolateral amygdala participate in the retrieval of morphine withdrawal memory with diverse molecular pathways
Context-induced retrieval of drug withdrawal memory is one of the important reasons for drug relapses. Previous studies have shown that different projection neurons in different brain regions or in the same brain region such as the basolateral amygdala (BLA) participate in context-induced retrieval of drug withdrawal memory. However, whether these different projection neurons participate in the retrieval of drug withdrawal memory with same or different molecular pathways remains a topic for research. The present results showed that (1) BLA neurons projecting to the prelimbic cortex (BLA-PrL) and BLA neurons projecting to the nucleus accumbens (BLA-NAc) participated in context-induced retrieval of morphine withdrawal memory; (2) there was an increase in the expression of Arc and pERK in BLA-NAc neurons, but not in BLA-PrL neurons during context-induced retrieval of morphine withdrawal memory; (3) pERK was the upstream molecule of Arc, whereas D1 receptor was the upstream molecule of pERK in BLA-NAc neurons during context-induced retrieval of morphine withdrawal memory; (4) D1 receptors also strengthened AMPA receptors, but not NMDA receptors, -mediated glutamatergic input to BLA-NAc neurons via pERK during context-induced retrieval of morphine withdrawal memory. These results suggest that different projection neurons of the BLA participate in the retrieval of morphine withdrawal memory with diverse molecular pathways.
- 26 December 2023
- Published by Springer Nature in Molecular Psychiatry
- Vol. 29 (3) , 793-808
Open AccessDifferent projection neurons of basolateral amygdala participate in the retrieval of morphine withdrawal memory with diverse molecular pathways
Context-induced retrieval of drug withdrawal memory is one of the important reasons for drug relapses. Previous studies have shown that different projection neurons in different brain regions or in the same brain region such as the basolateral amygdala (BLA) participate in context-induced retrieval of drug withdrawal memory. However, whether these different projection neurons participate in the retrieval of drug withdrawal memory with same or different molecular pathways remains a topic for research. The present results showed that (1) BLA neurons projecting to the prelimbic cortex (BLA-PrL) and BLA neurons projecting to the nucleus accumbens (BLA-NAc) participated in context-induced retrieval of morphine withdrawal memory; (2) there was an increase in the expression of Arc and pERK in BLA-NAc neurons, but not in BLA-PrL neurons during context-induced retrieval of morphine withdrawal memory; (3) pERK was the upstream molecule of Arc, whereas D1 receptor was the upstream molecule of pERK in BLA-NAc neurons during context-induced retrieval of morphine withdrawal memory; (4) D1 receptors also strengthened AMPA receptors, but not NMDA receptors, -mediated glutamatergic input to BLA-NAc neurons via pERK during context-induced retrieval of morphine withdrawal memory. These results suggest that different projection neurons of the BLA participate in the retrieval of morphine withdrawal memory with diverse molecular pathways.
- 7 April 2023
- Published by Wiley in Addiction Biology
- Vol. 28 (5) , e13277
Brain glucose metabolism and dopamine transporter changes in rats with morphine‐induced conditioned place preference
Addiction to morphine is a chronic brain disease leading to compulsive abuse. Drug addiction animal models with and without conditioned place preference (CPP) training have been used to investigate cue‐elicited drug craving. We used 18F‐fluorodeoxyglucose (18F‐FDG) and 11C‐2‐β‐carbomethoxy‐3‐β‐(4‐fluorophenyl)tropane (11C‐CFT) micro‐PET/CT scans to examine the regional changes in brain glucose metabolism and dopamine transporter (DAT) availability to study their relationship underlying drug memory in morphine‐treated rat models with and without CPP. Standardized uptake value ratio (SUVr) of 18F‐FDG significantly decreased in the medial prefrontal cortex (mPFC) and cingulate with short‐term morphine administration compared with the baseline condition. Voxelwise analysis indicated glucose metabolism alterations in the somatosensory cortex, hippocampus and cingulate in morphine‐treated rats and in the striatum, thalamus, medial prefrontal cortex, primary motor cortex and many regions in the cortex in the CPP group compared with the baseline condition. Alterative glucose metabolism was also observed in the striatum, primary somatosensory cortex and some cortical regions in the CPP group compared with morphine alone group. DAT expression alterations were only observed in the long‐term morphine compared with the short‐term morphine group. This study shows that cerebral glucose metabolism significantly altered during morphine administration and CPP process mainly in the mPFC, striatum and hippocampus, which indicates that the function of these brain regions is involved in cue‐induced craving and memory retrieval.
- 7 April 2023
- Published by Wiley in Addiction Biology
- Vol. 28 (5) , e13277
Brain glucose metabolism and dopamine transporter changes in rats with morphine‐induced conditioned place preference
Addiction to morphine is a chronic brain disease leading to compulsive abuse. Drug addiction animal models with and without conditioned place preference (CPP) training have been used to investigate cue‐elicited drug craving. We used 18F‐fluorodeoxyglucose (18F‐FDG) and 11C‐2‐β‐carbomethoxy‐3‐β‐(4‐fluorophenyl)tropane (11C‐CFT) micro‐PET/CT scans to examine the regional changes in brain glucose metabolism and dopamine transporter (DAT) availability to study their relationship underlying drug memory in morphine‐treated rat models with and without CPP. Standardized uptake value ratio (SUVr) of 18F‐FDG significantly decreased in the medial prefrontal cortex (mPFC) and cingulate with short‐term morphine administration compared with the baseline condition. Voxelwise analysis indicated glucose metabolism alterations in the somatosensory cortex, hippocampus and cingulate in morphine‐treated rats and in the striatum, thalamus, medial prefrontal cortex, primary motor cortex and many regions in the cortex in the CPP group compared with the baseline condition. Alterative glucose metabolism was also observed in the striatum, primary somatosensory cortex and some cortical regions in the CPP group compared with morphine alone group. DAT expression alterations were only observed in the long‐term morphine compared with the short‐term morphine group. This study shows that cerebral glucose metabolism significantly altered during morphine administration and CPP process mainly in the mPFC, striatum and hippocampus, which indicates that the function of these brain regions is involved in cue‐induced craving and memory retrieval.
- Open Access
- 5 January 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-16
Nucleus accumbens circuit disinhibits lateral hypothalamus glutamatergic neurons contributing to morphine withdrawal memory in male mice
The lateral hypothalamus (LH) is physiologically critical in brain functions. The LH also plays an important role in drug addiction. However, neural circuits underlying LH involvement of drug addiction remain obscure. In the present study,our results showed that in male mice, during context-induced expression of morphine withdrawal memory, LH glutamatergic neurons played an important role; dopamine D1 receptor-expressing medium spiny neurons (D1-MSNs) projecting from the core of nucleus accumbens (NAcC) to the LH were an important upstream circuit to activate LH glutamatergic neurons; D1-MSNs projecting from the NAcC to the LH activated LH glutamatergic neurons through inhibiting LH local gamma-aminobutyric acid (GABA) neurons. These results suggest that disinhibited LH glutamatergic neurons by neural circuits from the NAcC importantly contribute to context-induced the expression of morphine withdrawal memory.
- 5 January 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-16
Open AccessNucleus accumbens circuit disinhibits lateral hypothalamus glutamatergic neurons contributing to morphine withdrawal memory in male mice
The lateral hypothalamus (LH) is physiologically critical in brain functions. The LH also plays an important role in drug addiction. However, neural circuits underlying LH involvement of drug addiction remain obscure. In the present study,our results showed that in male mice, during context-induced expression of morphine withdrawal memory, LH glutamatergic neurons played an important role; dopamine D1 receptor-expressing medium spiny neurons (D1-MSNs) projecting from the core of nucleus accumbens (NAcC) to the LH were an important upstream circuit to activate LH glutamatergic neurons; D1-MSNs projecting from the NAcC to the LH activated LH glutamatergic neurons through inhibiting LH local gamma-aminobutyric acid (GABA) neurons. These results suggest that disinhibited LH glutamatergic neurons by neural circuits from the NAcC importantly contribute to context-induced the expression of morphine withdrawal memory.